Andrea Cobb Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1240 Main St, Oxford, ME 04270 Phone: 207-743-5466 |
Emily Benner, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1240 Main St, Oxford, ME 04270 Phone: 207-743-5466 |
Courtney Lynn Turgeon Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1603 Main St, Oxford, ME 04270 Phone: 207-743-7982 |
Tyler Caron, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1240 Main St, Oxford, ME 04270 Phone: 207-743-5466 |
Dr. Breanna Jean Copp-petersen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1603 Main St, Oxford, ME 04270 Phone: 207-743-7982 |
Brianna Gower Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1603 Main St, Oxford, ME 04270 Phone: 207-743-7982 |
David John Preble Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1603 Main St, Oxford, ME 04270 Phone: 207-743-7982 Fax: 207-743-5565 |
Rhonda Bates Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1240 Main St, Oxford, ME 04270 Phone: 207-743-5466 |
News Archive
An investigational stem cell therapy derived from patients' own blood marrow significantly improved outcomes in patients with severe heart failure, according to a study from the Cedars-Sinai Heart Institute.
Lawmakers are elbowing around Capitol Hill to cement their places in the coming fight over health reform, and industry groups are attempting the same.
Researchers addressed the question of using reporter particles pseudotyped with the S protein of SARS-CoV-2, which are suitable tools to examine SARS-CoV-2 neutralization antibodies.
Bionovo, Inc. has announced the online publication of a peer-reviewed article in the journal, Menopause, reporting Menerba (formerly MF101) is well tolerated, safe and effective for the treatment of vasomotor symptoms (hot flashes and night sweats) associated with menopause.
New data from a study of patients with treatment-resistant depression who underwent deep brain stimulation (DBS) in the subcallosal cingulate region (SCG or Cg25) of the brain shows that this intervention is generally safe and provides significant improvement in patients as early as one month after treatment. The patients also experienced continued and sustained improvement over time.
› Verified 1 days ago